Volume 67, Issue 5, Pages (May 2015)

Slides:

Advertisements

Similar presentations

Volume 68, Issue 6, Pages (December 2015)

Advertisements

Volume 52, Issue 1, Pages (July 2007)

Volume 165, Issue 5, Pages (May 2001)

Volume 172, Issue 6, Pages (December 2004)

Volume 105, Issue 3, Pages (March 1994)

Volume 68, Issue 3, Pages (September 2015)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Volume 55, Issue 2, Pages (February 2009)

Testosterone Therapy in Men With Prostate Cancer

Volume 58, Issue 5, Pages (November 2010)

Volume 58, Issue 1, Pages (July 2010)

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer Francesco Cantiello, Giorgio.

Volume 66, Issue 1, Pages (July 2014)

Volume 61, Issue 5, Pages (May 2012)

Volume 51, Issue 1, Pages (January 2007)

Volume 63, Issue 4, Pages (April 2013)

Volume 52, Issue 3, Pages (September 2007)

Volume 51, Issue 3, Pages (March 2007)

European Urology Oncology

The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy Olaf A. Brinkmann,

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Volume 51, Issue 5, Pages (May 2007)

Volume 52, Issue 4, Pages (October 2007)

Volume 61, Issue 4, Pages (April 2012)

Volume 66, Issue 3, Pages (September 2014)

Volume 63, Issue 4, Pages (April 2013)

Volume 66, Issue 3, Pages (September 2014)

Volume 59, Issue 2, Pages (February 2011)

Volume 63, Issue 1, Pages (January 2013)

Volume 52, Issue 1, Pages (July 2007)

Volume 66, Issue 2, Pages (August 2014)

Nomograms for Bladder Cancer

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 73, Issue 2, Pages (February 2018)

Volume 61, Issue 5, Pages (May 2012)

Volume 55, Issue 2, Pages (February 2009)

Volume 52, Issue 1, Pages (July 2007)

Volume 58, Issue 4, Pages (October 2010)

Volume 71, Issue 5, Pages (May 2017)

Volume 60, Issue 5, Pages (November 2011)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 2, Pages (February 2008)

Stephen B. Williams, Ashish M

Volume 64, Issue 4, Pages (October 2013)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 66, Issue 6, Pages (December 2014)

Volume 66, Issue 2, Pages (August 2014)

Volume 63, Issue 3, Pages (March 2013)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 62, Issue 2, Pages (August 2012)

Volume 59, Issue 1, Pages (January 2011)

European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update

Volume 56, Issue 5, Pages (November 2009)

Volume 53, Issue 1, Pages (January 2008)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 71, Issue 5, Pages (May 2017)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Volume 51, Issue 6, Pages (June 2007)

Volume 52, Issue 4, Pages (October 2007)

Volume 52, Issue 1, Pages (July 2007)

Carcinoma of the esophagus: Prognostic significance of histologic type

Neal S Goldstein, MD The Annals of Thoracic Surgery

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 67, Issue 5, Pages 943-951 (May 2015) Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1–pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? Sabine D. Brookman-May, Matthias May, Ingmar Wolff, Richard Zigeuner, Georg C. Hutterer, Luca Cindolo, Luigi Schips, Ottavio De Cobelli, Bernardo Rocco, Cosimo De Nunzio, Andrea Tubaro, Ioman Coman, Michael Truss, Orietta Dalpiaz, Bogdan Feciche, Robert S. Figenshau, Kerry Madison, Manuel Sánchez-Chapado, Maria del Carmen Santiago Martin, Luigi Salzano, Giuseppe Lotrecchiano, Stefan Zastrow, Manfred Wirth, Petros Sountoulides, Shahrokh Shariat, Raphaela Waidelich, Christian Stief, Sven Gunia European Urology Volume 67, Issue 5, Pages 943-951 (May 2015) DOI: 10.1016/j.eururo.2014.11.055 Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 1 Kaplan-Meier cancer-specific survival estimates for 7384 renal cell carcinoma patients (all N0M0) with tumor stage pT1–2 (n=6137), tumor stage pT3a with perirenal fat invasion only (PFI, n=1036), and tumor stage pT3a with renal vein involvement with or without PFI (RVI, n=211). pT1–2 versus PFI, p<0.001; pT1–2 versus RVI, p<0.001; PFI versus RVI, p=0.026. European Urology 2015 67, 943-951DOI: (10.1016/j.eururo.2014.11.055) Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 2 Kaplan-Meier cancer-specific survival estimates for 7384 patients with pT1–2N0M0 (n=6137), pT3aN0M0 ≤7cm (n=880), and pT3aN0M0 >7cm (n=578) renal cell carcinoma. pT1–2 versus pT3 ≤7cm, pT1–2 versus pT3 >7cm, and pT3 ≤7cm versus pT3 >7cm all p<0.001. European Urology 2015 67, 943-951DOI: (10.1016/j.eururo.2014.11.055) Copyright © 2014 European Association of Urology Terms and Conditions